The U.S. Food and Drug Administration said on Thursday its preliminary review did not find…
/cloudfront-us-east-2.images.arcpublishing.com/reuters/UIHKLYV3UJL4TJ4OBBFDNOID44.jpg "Auto Draft")
PHARMA & CLINICAL TRIALS
/cloudfront-us-east-2.images.arcpublishing.com/reuters/KNWLDKTDOZLJLEMHF7XWSIMTHM.jpg "US FDA Identifies Recall of ResMed’s Respiratory Devices as Most Serious")
The U.S. Food and Drug Administration (FDA) on Thursday classified the recall of certain respiratory…
Physicians who are notified that a patient has died of a drug overdose are more…
Alira Health and Sancare announced the launch of their partnership today. The companies are joining…
Accenture announced it has made a strategic investment, through Accenture Ventures, in QuantHealth, an AI-powered clinical…
AbbVie Launches PRODUODOPA for People Living with Advanced Parkinson’s Disease in the European Union
– PRODUODOPA (foslevodopa/foscarbidopa) is the first-and-only subcutaneous 24-hour infusion of levodopa-based therapy for the treatment…
TALZENNA is the first and only PARP inhibitor approved in combination with standard of care…
Pfizer has announced that the U.S. Food and Drug Administration (FDA) has accepted the supplemental…
The University of Rochester will house a new national center focused on using tissue-on-chip technology to develop…
Merck and Harpoon Therapeutics today announced that the companies have entered into a definitive agreement…
